| PERIOD ENDING | 24-Oct-09 | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | | Total Revenue | 259,116 | 269,691 | 257,720 | 245,522 | | Cost of Revenue | 209,971 | 213,646 | 206,733 | 205,860 | | | Gross Profit | 49,145 | 56,045 | 50,987 | 39,662 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,502 | 25,382 | 24,276 | 21,534 | | Non Recurring |
-
|
-
|
-
| 94,429 | | Others | 15,191 | 15,843 | 16,163 | 16,817 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,452 | 14,820 | 10,548 | (93,118) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,140 | 792 | 3,625 | 1,871 | | Earnings Before Interest And Taxes | 11,592 | 15,612 | 14,173 | (91,247) | | Interest Expense | 3,544 | 3,430 | 3,162 | 4,099 | | Income Before Tax | 8,048 | 12,182 | 11,011 | (95,346) | | Income Tax Expense | 4,525 | 5,477 | 3,442 | (17,392) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,523 | 6,705 | 7,569 | (77,954) | | | Non-recurring Events | | Discontinued Operations |
-
| (77) | 28 | 1 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,523 | 6,628 | 7,597 | (77,953) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,523 | $6,628 | $7,597 | ($77,953) |
|
0.51% Nasdaq 
Income Statement
